Benzinga | Aug 6, 2020 04:20PM EDT

Aerie Pharmaceuticals Q2 EPS $(0.83) Misses $(0.80) Estimate, Sales $18.03M Beat $17.45M Estimate

Aerie Pharmaceuticals (NASDAQ:AERI) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.80) by 3.75 percent. This is a 3.75 percent decrease over losses of $(0.80) per share from the same period last year. The company reported quarterly sales of $18.03 million which beat the analyst consensus estimate of $17.45 million by 3.34 percent. This is a 13.88 percent increase over sales of $15.84 million the same period last year.